Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation | Patent Publication Number 20140308344

US 20140308344 A1
Patent NumberUS 09101621 B2
Application Number14255211
Filled DateApr 17, 2014
Priority DateMay 17, 2002
Publication DateOct 16, 2014
Original AssigneeBristol Myers Squibb
Current AssigneeCelgene
Inventor/ApplicantsJerome B. Zeldis
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.